Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.
about
Galactomannan testing for early diagnosis of Exserohilum rostratum infectionDiagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Pulmonary aspergillosis as opportunistic mycoses in a cohort of human immunodeficiency virus-infected patients: Report from a tertiary care hospital in North India.Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United StatesHost biomarkers of invasive pulmonary aspergillosis to monitor therapeutic responseUse and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum.Analysis of performance of a PCR-based assay to detect DNA of Aspergillus fumigatus in whole blood and serum: a comparative study with clinical samplesMulticenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patientsGalactomannan antigenemia after infusion of gluconate-containing Plasma-Lyte.Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis.Nosocomial fungal infections: epidemiology, diagnosis, and treatment.Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillanceChanging landscape of invasive aspergillosis in allogeneic stem cell transplant recipients.Serum galactomannan assay for diagnosis of probable invasive Aspergillosis in acute leukemia and hematopoietic stem cell transplantation.Galactofuranose containing molecules in Aspergillus fumigatus.Current status and future perspectives on molecular and serological methods in diagnostic mycology.Opportunistic invasive fungal infections: diagnosis & clinical management.Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.Invasive aspergillosis in children with acquired immunodeficiencies.Utility of galactomannan antigen detection in bronchoalveolar lavage fluid in immunocompromised patients.Invasive pulmonary mycosis due to Chaetomium globosum with false-positive galactomannan test: a case report and literature review.Pulmonary toxocariasis mimicking invasive aspergillosis in a patient with ulcerative colitis.Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia.Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study.Why is biopsy of suspected fungal lung lesions necessary?Gluconate-containing intravenous solutions: another cause of false-positive galactomannan assay reactivity.Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid.False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics.The effect of sample storage on the performance and reproducibility of the galactomannan EIA test.Diagnostic value of the serum galactomannan assay for invasive aspergillosis: it is less useful in non-haematological patients.The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study.Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.Serum galactomannan antigen as a prognostic and diagnostic marker for invasive aspergillosis in heterogeneous medicine ICU patient population.Novel mouse monoclonal antibodies specifically recognize Aspergillus fumigatus galactomannan.Evaluation of noninvasive methods for the diagnosis of fungal endocarditis.Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age.Sputum signatures for invasive pulmonary aspergillosis in patients with underlying respiratory diseases (SPARED): study protocol for a prospective diagnostic trial.
P2860
Q28291634-33B5962B-6FDA-4985-A22F-198C186CB9E6Q30608976-53E8EE9A-E90F-4F55-9F3C-D2C5D888DC68Q33662384-68C0623E-C34B-4F12-AB69-EB7B863BAA59Q33703566-D1C8F7EA-9D36-4626-8C91-1F765CC8A49AQ33798161-46A3F8A9-111F-41A1-9036-624E0E3B411AQ33900089-12E51721-5936-4276-B04C-66595778B594Q34489333-E85A0738-3866-47C8-A886-EE5F27ED4D41Q34719835-54D090E4-42E5-4CF6-AF8F-D37C50B2101CQ35073287-AB8A7B8F-2A64-4AB0-BFE4-C94A9C16DA37Q35273787-159AF58F-CF4B-41C2-B08B-8AA481DBAD8AQ35575320-B4105A44-3524-4632-BC29-2A084A4B582CQ35598876-847B664C-6154-48ED-A041-03C55BDEA5B6Q36746929-C895A1F4-AD45-4B20-B849-9298F16400F2Q36825717-F866D56E-484D-4DC4-B052-82DA4B9BF025Q36957891-09B83895-97A7-43A5-BE6E-B345083B29F1Q37081683-F63BF27E-774A-4AC9-A147-844C474713CDQ37150921-CD9E9DBA-444F-4813-953B-3F682BF425F2Q37237487-C2B6A1DA-05AB-4F82-BDE6-0AC882070F88Q37628677-7D7C64E8-9F5E-43DD-B719-2D7EFA1CFB82Q37726198-52406BA6-177B-4421-9DDA-D0D575A73708Q37854718-18006BA9-5623-4A47-B31E-6912CE5F8BB9Q37954958-AC65C6C3-D86D-4F76-867E-2EA00832EE6EQ38089915-54EC9C52-52D1-4C56-9E8E-6458D7BBC509Q38675812-05579404-3C4C-49D2-981F-0D1D1F95ED3DQ40189902-AC0A8F85-861C-4C30-AD0C-89089DF9CDD8Q40424803-2441AB6C-B68B-49EC-8998-F760DC69214CQ41038249-825A8CF2-22CA-4BBB-9C54-E236B67D39C6Q41860895-7F990C32-E525-4AB3-A5C4-E9D41DCBC0BCQ42798782-7C726F53-9923-4484-8BF0-9A9CE5AD9064Q42912557-B9CA5EE2-8644-46AC-90B8-055377519928Q43146182-703C6A39-3DD8-43D0-8C9C-C5E90141706FQ43406268-D0CBDDA9-930B-4D20-9192-23FC01C31845Q44368832-CDFB236F-111D-4209-B19F-B11DB39AA1BAQ49591743-E4457C1E-FF11-46FB-940C-1A3DD4D38B2CQ51047839-96A602E9-394A-459B-827A-5F841E5C05A9Q52570071-25F0B9BC-8B9D-4A82-8F94-1EAD0CF9F7ECQ52666779-79173722-AD92-4A75-86DB-6233AF9796E1Q53840566-102FE08F-D61F-46D7-9C5D-FBB8F25697FBQ55241833-54C679AF-161E-44CA-A8C9-F3BE601A798AQ55281032-C1A79A70-45E6-4881-9AD3-CE860D6F6494
P2860
Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Occurrence and kinetics of fal ...... with hematological disorders.
@ast
Occurrence and kinetics of fal ...... with hematological disorders.
@en
Occurrence and kinetics of fal ...... with hematological disorders.
@nl
type
label
Occurrence and kinetics of fal ...... with hematological disorders.
@ast
Occurrence and kinetics of fal ...... with hematological disorders.
@en
Occurrence and kinetics of fal ...... with hematological disorders.
@nl
prefLabel
Occurrence and kinetics of fal ...... with hematological disorders.
@ast
Occurrence and kinetics of fal ...... with hematological disorders.
@en
Occurrence and kinetics of fal ...... with hematological disorders.
@nl
P2093
P2860
P1476
Occurrence and kinetics of fal ...... s with hematological disorders
@en
P2093
Alban Aubry
Annie Sulahian
Benoît Brethon
Emmanuel Raffoux
Francis Derouin
Jean Menotti
Julie Bottero
Patricia Ribaud
Philippe Rousselot
Thierry Leblanc
P2860
P304
P356
10.1128/JCM.44.2.389-394.2006
P407
P577
2006-02-01T00:00:00Z